Study S001756

Effect of Early Combination Antihyperglycemic Treatment With Metformin and Oral Semaglutide vs. Metformin and Empagliflozin on Glycemic and Metabolic Control in Individuals With Short Duration Type 2 Diabetes

ClinicalTrials.gov record

Registration

Registration: NCT06613854
Acronym: E-SEMPA
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: NONE
Status: RECRUITING
Enrollment: 90
Start: 2024-10-01
Primary completion: 2027-09
Lead sponsor: University Medical Centre Ljubljana
Conditions: Type 2 Diabetes Mellitus (T2DM)
Interventions: DRUG:Oral semaglutide; DRUG:Empagliflozin 10 mg
Results posted: FALSE
Individual participant data sharing: NO
Secondary identifiers: OTHER:0120-70/2024-2711-3

Registered primary outcomes

Time in Range (TIR) [Period of 14 days prior to last study visit (week 26)]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.